| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 12,372,000 | 13,028,000 | 12,904,000 | 11,604,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 12,372,000 | 13,028,000 | 12,904,000 | 11,604,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,023,000 | 1,042,000 | 65,000 | 895,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,682,000 | 7,847,000 | 8,057,000 | 2,283,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,667,000 | 4,139,000 | 4,782,000 | 8,426,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (1,084,000) |
-
| | Earnings Before Interest And Taxes | 5,664,000 | 4,139,000 | 3,716,000 | 8,430,000 | | Interest Expense | 8,407,000 | 9,252,000 | 9,886,000 | 10,414,000 | | Income Before Tax | (2,743,000) | (5,113,000) | (6,170,000) | (1,984,000) | | Income Tax Expense | (476,000) | (2,928,000) | (2,623,000) | (582,000) | | Minority Interest | (3,000) |
-
| 18,000 | 4,000 | | | | Net Income From Continuing Ops | (2,267,000) | (2,185,000) | (3,547,000) | (1,402,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items | (33,000) | (1,000) | (12,000) | 3,000 | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,300,000) | (2,186,000) | (3,559,000) | (1,399,000) | | Preferred Stock And Other Adjustments | (303,000) | (322,000) | (141,000) | (119,000) | | | Net Income Applicable To Common Shares | ($2,603,000) | ($2,508,000) | ($3,700,000) | ($1,518,000) |
|
1.49% Nasdaq 0.00%
Income Statement
